Chromoblastomycosis: an etiological, epidemiological, clinical, diagnostic, and treatment update
Tóm tắt
Từ khóa
Tài liệu tham khảo
McGinnis MR, 1983, Chromoblastomycosis and phaeohyphomycosis: new concepts, diagnosis, and mycology, J Am Acad Dermatol, 8, 1, 10.1016/S0190-9622(83)70001-0
Rubin HA, 1991, Evidence for percutaneous inoculation as the mode of transmission for chromoblastomycosis, J Am Acad Dermatol, 25, 951, 10.1016/0190-9622(91)70292-A
Terra F, 1922, Novo tipo de dermatite verrucosa; micose por Acrotheca com associado de leishmaniose, Brasil Medico, 36, 363
Odds FC, 1992, Nomenclature of fungal diseases: a report and recommendations from a Sub-Committee of the International Society for Human and Animal Mycology (ISHAM), J Med Vet Mycol, 30, 1, 10.1080/02681219280000021
Pedroso A, 1920, 4 casos de dermatite verrucosa produzida pela Phialophora verrucosa, Ann Paul Med Cir, 11, 53
Brumpt E, 1922, 3rd ed
Negroni R, 1936, Estudio del primer caso argentino de cromomicosis, Fonsecaea (Negroni) pedrosoi (Brumpt) 1921, Rev Inst Bacteriol, 7, 419
Castro RM, 1987, On the priority of description of chromomycosis, Mykosen, 30, 397, 10.1111/j.1439-0507.1987.tb03636.x
Rudolph MW, 1914, Über die brasilianische "Figueira" Arch Schiffs. für, Tropen-Hygien, 18, 498
Medlar EM, 1915, A cutaneous infection caused by a new fungus Phialophora verrucosa, with a study of the fungus, J Med Res, 32, 507
Lane CG, 1915, A cutaneous disease caused by a new fungus Phialophora verrucosa, J Cutan Dis, 33, 840
Hoffman WH, 1928, Die Chromoblastomykose in Kuba, Arch SchiffsTropen-Hyg, 32, 485
Montpellier J, 1927, Mycosehumaine due à une champignon de genre Hormodendrum, H algeriensisn.sp. Ann, Dermatol Syphilol, 8, 626
Wilson SJ, 1933, Chromoblastomycosis in Texas, Arch Dermatol Syphilol, 27, 107, 10.1001/archderm.1933.01450040110010
Moore M, 1935, Etiologic agents of chromycosis (Chromoblastomycosis of Terra Torres, Fonseca and Leão, 1922) of North and South America, Rev Biol Hyg, 6, 94
Rippon JW, 1982, 2nd ed
Borelli D, 1972, Acrotheca aquaspersa: nova species agente de Cromomicosis, Acta Cient Venez, 23, 193
De Hoog GS, 2000, Black fungi: clinical and pathogenic approaches, Med Mycol, 38, 243, 10.1080/714030907
Kwon-Chung KJ, 1992, Chromoblastomycosis, 337
Najafzadeh MJ, 2010, Fonsecaea nubica sp nov, a new agent of human chromoblastomycosis revealed using molecular data, Med Mycol, 48, 800, 10.3109/13693780903503081
de Azevedo CM, 2015, Fonsecaea pugnacius, a Novel Agent of Disseminated Chromoblastomycosis, J Clin Microbiol, 53, 2674, 10.1128/JCM.00637-15
Queiroz-Telles F, 2009, Chromoblastomycosis: an overview of clinical manifestations, diagnosis and treatment, Med Mycol, 47, 3, 10.1080/13693780802538001
Gomes RR, 2016, Molecular epidemiology of agents of human Chromoblastomycosis in Brazil with the description of two novel specieis, PLoS Negl Trop Dis, 10, 10.1371/journal.pntd.0005102
Heidrich D, 2017, Chromoblastomycosis caused by Rhinocladiella similis: Case report, Med Mycol Case Rep, 16, 25, 10.1016/j.mmcr.2017.04.002
De Hoog GS, 2004, Molecular ecology and pathogenic potential of Fonsecaea species, Med Mycol, 42, 405, 10.1080/13693780410001661464
Pérez-Blanco M, 2006, Chromoblastomycosis in children and adolescents in the endemic area of the Falcon State, Venezuela, Med Mycol, 44, 467, 10.1080/13693780500543238
Queiroz-Telles F, 2011, Mycoses of implantation in Latin America: an overview of epidemiology, clinical manifestations, diagnosis and treatment, Med Mycol, 49, 225, 10.3109/13693786.2010.539631
Bonifaz A, 2001, Chromoblastomycosis: clinical and mycologic experience of 51 cases, Mycoses, 44, 1, 10.1046/j.1439-0507.2001.00613.x
Silva JP, 1999, Chromoblastomycosis: a retrospective study of 325 cases on Amazonic Region (Brazil), Mycopathologia, 143, 171, 10.1023/A:1006957415346
Naka W, 1986, A case of chromoblastomycosis: with special reference to the mycology of the isolated Exophiala jeanselmei, Mykosen, 29, 445, 10.1111/j.1439-0507.1986.tb03943.x
Barba-Gómez JF, 1992, Chromoblastomycosis caused by Exophiala spinifera, J Am Acad Dermatol, 26, 367, 10.1016/0190-9622(92)70058-N
Padhye AA, 1996, Chromoblastomycosis caused by Exophiala spinifera, Clin Infect Dis, 22, 331, 10.1093/clinids/22.2.331
Tomson N, 2006, Chromomycosis caused by Exophiala spinifera, Clin Exp Dermatol, 31, 239, 10.1111/j.1365-2230.2005.02006.x
Piepenbring M, 2007, Chromoblastomycosis caused by Chaetomium funicola: a case report from Western Panama, Br J Dermatol, 157, 1025, 10.1111/j.1365-2133.2007.08091.x
Matsumoto T, 1993, Clinical and mycological spectra of Wangiella dermatitidis infections, Mycoses, 36, 145, 10.1111/j.1439-0507.1993.tb00743.x
Schnitzler N, 1999, Effect of melanin and carotenoids of Exophiala (Wangiella) dermatitidis on phagocytosis, oxidative burst, and killing by human neutrophils, Infect Immun, 67, 94, 10.1128/IAI.67.1.94-101.1999
Brygoo ER, 1975, Epidemiologie de la chromoblastomycose humaine, Bull Inst Pasteur, 74, 219
Esterre P, 1997, Natural history of chromoblastomycosis in Madagascar and the Indian Ocean, Bull Soc Pathol Exot, 90, 312
Berger L, 1949, Sur un type noveau de chromomycose observé au Canada (Torulabergeri n sp), Ann Parasitol Hum Comp, 24, 574, 10.1051/parasite/1949245574
Putkonen T, 1966, Chromomycosis in Finland The possible role of the Finnish sauna in its spreading, Hautarzt, 17, 507
Sonck CE, 1975, Chromomycosis in Finland, Dermatology, 19, 189
Pindycka-Piaszczynska M, 2014, Chromoblastomycosis as an endemic disease in temperate Europe: first confirmed case and review of the literature, Eur J Clin Microbiol Infect Dis, 33, 391, 10.1007/s10096-013-1969-7
Nishimoto K, 1981, Chromomycosis in Japan, Ann Soc Belg Med Trop, 61, 405
Fukushiro R, 1983, Chromomycosis in Japan, Int J Dermatol, 22, 221, 10.1111/j.1365-4362.1983.tb03371.x
Campins H, 1953, Chromoblastomicosis: comentarios sobre 34 casos con estudio clínico, histológico y micológico, Gac Med (Caracas), 61, 127
Minotto R, 2001, Chromoblastomycosis: a review of 100 cases in the state of Rio Grande do Sul, Brazil, J Am Acad Dermatol, 44, 585, 10.1067/mjd.2001.112220
Lacaz CS, 1991, 8th ed
Conant NF, 1937, The occurrence of a human pathogenic fungus as a saprophyte in nature, Mycologia, 29, 597, 10.2307/3754512
Silva ACCM, 1992, Cromoblastomicose produzida por Fonsecaea pedrosoi no estado do Maranhão I. Aspectos clínicos, epidemiológicos e evolutivos, Rev Soc Bras Med Trop, 25, 37, 10.1590/S0037-86821992000100006
Londero AT, 1976, Chromomycosis: a clinical and mycologic study of thirty-five cases observed in the hinterland of Rio Grande do Sul, Brazil, Am J Trop Med Hyg, 25, 132, 10.4269/ajtmh.1976.25.132
Silva CM, 1995, The coconut babaçu (Orbignyaphalerata martins) as a probable risk of human infection by the agent of chromoblastomycosis in the State of Maranhão, Brazil, Rev Soc Bras Med Trop, 28, 49
Salgado CG, 2004, Isolation of Fonsecaea pedrosoi from thorns of Mimosa pudica, a probable natural source of chromoblastomycosis, Rev Inst Med Trop Sao Paulo, 46, 33, 10.1590/S0036-46652004000100006
Zeppenfeldt G, 1994, Cladosporium carrionii: hongo dimórfico en cactáceas de la zona endémica para la cromomicosis en Venezuela, Rev Iberoam Micol, 11, 61
d'Avila SC, 2003, The cell-mediated immune reaction in the cutaneous lesion of chromoblastomycosis and their correlation with different clinical forms of the disease, Mycopathologia, 156, 51
Sousa MG, 2008, Fonsecaea pedrosoi infection induces differential modulation of costimulatory molecules and cytokines in monocytes from patients with severe and mild forms of chromoblastomycosis, J Leukoc Biol, 84, 864, 10.1189/jlb.0308211
Nimrichter L, 2004, A monoclonal antibody to glucosylceramide inhibits the growth of Fonsecaea pedrosoi and enhances the antifungal action of mouse macrophages, Microbes Infect, 6, 657, 10.1016/j.micinf.2004.03.004
Hayakawa M, 2006, Phagocytosis, production of nitric oxide and pro-inflammatory cytokines by macrophages in the presence of dematiaceous fungi that cause chromoblastomycosis, Scand J Immunol, 64, 382, 10.1111/j.1365-3083.2006.01804.x
Bocca AL, 2006, Inhibition of nitric oxide production by macrophages in chromoblastomycosis: a role for Fonsecaea pedrosoi melanin, Mycopathologia, 161, 195, 10.1007/s11046-005-0228-6
Sotto MN, 2004, Antigen distribution and antigen-presenting cells in skin biopsies of human chromoblastomycosis, J Cutan Pathol, 31, 14, 10.1046/j.0303-6987.2004.0131.x
Mazo Fávero Gimenes V, 2005, Cytokines and lymphocyte proliferation in patients with different clinical forms of chromoblastomycosis, Microbes Infect, 7, 708, 10.1016/j.micinf.2005.01.006
da Silva JP, 2007, Phagocytosis of Fonsecaea pedrosoi conidia, but not sclerotic cells caused by Langerhans cells, inhibits CD40 and B7-2 expression, FEMS Immunol Med Microbiol, 50, 104, 10.1111/j.1574-695X.2007.00239.x
Silva AA, 2014, In Situ Immune Response in Human Chromoblastomycosis - A Possible Role for Regulatory and Th17 T Cells, PLoS Negl Trop Dis, 8, 10.1371/journal.pntd.0003162
Siqueira IM, 2017, Modulation of the immune response by Fonsecaea pedrosoi morphotypes in the course of experimental chromoblastomycosis and their role on inflammatory response chronicity, PLoS Negl Trop Dis, 11, 10.1371/journal.pntd.0005461
Carrión AL, 1950, Chromoblastomycosis, Ann N Y Acad Sci, 50, 1255, 10.1111/j.1749-6632.1950.tb39826.x
Salgado CG, 2009, Cutaneous localized annular chromoblastomycosis, J Cutan Pathol, 36, 257, 10.1111/j.1600-0560.2008.01025.x
Salgado CG, 2005, Cutaneous diffuse chromoblastomycosis, Lancet Infect Dis, 5, 528, 10.1016/S1473-3099(05)70195-X
Krishna S, 2016, Two cases of axillary chromoblastomycosis, Indian J Dermatol Venereol Leprol, 82, 455, 10.4103/0378-6323.174415
El Euch D, 2010, Erythemato-squamous papular and atrophic plaque on abdomen: chromoblastomycosis due to Fonsecaeapedrosoi, Med Trop (Mars), 70, 81
Bui AQ, 2012, Chromoblastomycosis of the conjunctiva mimicking melanoma of the ciliary body, Arch Ophthalmol, 130, 1615, 10.1001/archophthalmol.2012.1573
Bittencourt AL, 1994, Cromoblastomicose auricular: relato de um caso, Rev Inst Med trop São Paulo, 36, 381, 10.1590/S0036-46651994000400014
França K, 2011, Auricular Chromoblastomycosis: A Case Report and Review of Published Literature, Mycopathologia, 172, 69, 10.1007/s11046-011-9396-8
Arango M, 1998, Auricular chromoblastomycosis caused by Rhinocladiella aquaspersa, Med Mycol, 36, 43, 10.1080/02681219880000071
Muñoz Estrada VF, 2011, Cromomicosis: Reporte de un caso contopografía atípica, Rev Iberoam Micol, 28, 50, 10.1016/j.riam.2010.11.006
Naveen KN, 2012, Chromoblastomycosis presenting as a phagedenic ulcer on the face, Int J Dermatol, 51, 576, 10.1111/j.1365-4632.2011.05088.x
Fatemi MJ, 2012, Oral chromoblastomycosis: a case report, Iran J Microbiol, 4, 40
Takase T, 1988, Chromomycosis A case with a widespread rash, lymph node metastasis and multiple subcutaneous nodules, Mycoses, 31, 343, 10.1111/j.1439-0507.1988.tb04429.x
Camara-Lemarroy CR, 2013, Case of chromoblastomycosis with pulmonary involvement, J Dermatol, 40, 746, 10.1111/1346-8138.12216
Sharma NL, 2007, Chromoblastomycosis with underlying osteolytic lesion, Mycoses, 50, 517, 10.1111/j.1439-0507.2007.01398.x
Queiroz-Telles F, 2003, Subcutaneous mycoses, Infect Dis Clin North Am, 17, 59, 10.1016/S0891-5520(02)00066-1
Sharma N, 2009, Genital elephantiasis as a complication of chromoblastomycosis: A diagnosis overlooked, Indian J Sex Transm Dis, 30, 43, 10.4103/0253-7184.55486
Caplan RM, 1968, Epidermoid carcinoma arising in extensive chromoblastomycosis, Arch Dermatol, 97, 38, 10.1001/archderm.1968.01610070044007
Foster HM, 1987, Malignant change (squamous carcinoma) in chronic chromoblastomycosis, Aust N Z J Surg, 57, 775, 10.1111/j.1445-2197.1987.tb01260.x
Esterre P, 1999, Squamous cell carcinoma arising from chromomycosis Report of two cases, Ann Pathol, 19, 516
dos Santos Gon A, 2006, Melanoma in a long-standing lesion of chromoblastomycosis, Int J Dermatol, 45, 1331, 10.1111/j.1365-4632.2006.02757.x
Torres E, 2010, Chromoblastomycosis associated with a lethal squamous cell carcinoma, An Bras Dermatol, 85, 267
Jamil A, 2012, Invasive squamous cell carcinoma arising from chromoblastomycosis, Med Mycol, 50, 99, 10.3109/13693786.2011.571295
Azevedo CM, 2015, Squamous cell carcinoma derived from chronic chromoblastomycosis in Brazil, Clin Infect Dis, 60, 1500, 10.1093/cid/civ104
Rojas OC, 2015, Chromoblastomycosis by Cladophialophora carrionii associated with squamous cell carcinoma and review of published reports, Mycopathologia, 179, 153, 10.1007/s11046-014-9824-7
Miranda MF, 2005, Vinyl adhesive tape also effective for direct microscopy diagnosis of chromomycosis, lobomycosis, and paracoccidioidomycosis, 52, 39
de Andrade TS, 2007, Rapid identification of Fonsecaea by duplex polymerase chain reaction in isolates from patients with chromoblastomycosis, Diagn Microbiol Infect Dis, 57, 267, 10.1016/j.diagmicrobio.2006.08.024
Oberto-Perdigón L, 2005, An ELISA test for the study of the therapeutic evolution of chromoblastomycosis by Cladophialophora carrionii in the endemic area of Falcon State, Venezuela, Rev Iberoam Micol, 22, 39
Lee MW, 1998, Spores and mycelia in cutaneous chromomycosis, J Am Acad Dermatol, 39, 850, 10.1016/S0190-9622(98)70364-0
Avelar-Pires C, 2013, Revisiting the clinical and histopathological aspects of patients with chromoblastomycosis from the Brazilian Amazon region, Arch Med Res, 44, 302, 10.1016/j.arcmed.2013.04.008
Lokuhetty MD, 2007, ZeilNeelson and Wade-Fite stains to demonstrate medlar bodies of chromoblastomycosis, J Cutan Pathol, 34, 71, 10.1111/j.1600-0560.2006.00572.x
Saxena AK, 2015, Chromoblastomycosis: demonstration of abundant microorganisms on microscopy of a scaly crust following intralesional corticosteroids, J Eur Acad Dermatol Venereol, 29, 189, 10.1111/jdv.12389
Bonifaz A, 2004, Treating chromoblastomycosis with systemic antifungals, Expert Opin Pharmacother, 5, 247, 10.1517/14656566.5.2.247
Bonifaz A, 1997, Treatment of chromoblastomycosis with itraconazole, cryosurgery and a combination of both, Int J Dermatol, 36, 542, 10.1046/j.1365-4362.1997.00085.x
Castro LG, 2003, Treatment of chromomycosis by cryosurgery with liquid nitrogen: 15 years'experience, Int J Dermatol, 42, 408, 10.1046/j.1365-4362.2003.01532.x
Tagami H, 1984, Successful treatment of chromoblastomycosis with topical heat therapy, J Am Acad Dermatol, 10, 615, 10.1016/S0190-9622(84)80266-2
Hiruma M, 1993, Hyperthermic treatment of chromomycosis with disposable chemicalpocket warmers Report of a successfully treated case, with a review of the literature, Mycopathologia, 122, 107, 10.1007/BF01103608
Tsianakas A, 2008, Chromomycosis: successful CO2 laser vaporization, J Eur Acad Dermatol Venereol, 22, 1385, 10.1111/j.1468-3083.2008.02649.x
Hira K, 2002, Successful treatment of chromomycosis using carbon dioxide laser associated with topical heat applications, J Eur Acad Dermatol Venereol, 16, 273, 10.1046/j.1468-3083.2002.00479.x
Lyon JP, 2011, Photodynamic antifungal therapy against chromoblastomycosis, Mycopathologia, 172, 293, 10.1007/s11046-011-9434-6
Yang Y, 2012, A refractory case of chromoblastomycosis due to Fonsecaea monophora with improvement by photodynamic therapy, Med Mycol, 50, 649, 10.3109/13693786.2012.655258
Hu Y, 2015, Photodynamic therapy combined with terbinafine against chromoblastomycosis and the effect of PDT on Fonsecaea monophora in vitro, Mycopathologia, 179, 103, 10.1007/s11046-014-9828-3
Pavlidakey GP, 1986, Chromoblastomycosis treated by Mohs micrographic surgery, J Dermatol Surg Oncol, 12, 1073, 10.1111/j.1524-4725.1986.tb02085.x
Bonifaz A, 2001, Chromoblastomycosis; clinical and mycologic experience of 51 cases, Mycoses, 44, 1, 10.1046/j.1439-0507.2001.00613.x
Esterre P, 1996, Treatment of chromomycosis with terbinafine: preliminary results of an open pilot study, Br J Dermatol, 134, 33, 10.1111/j.1365-2133.1996.tb15658.x
Queiroz-Telles F, 2003, Subcutaneous mycoses, Infect Dis Clin North Am, 17, 59, 10.1016/S0891-5520(02)00066-1
Bonifaz A, 2005, Treatment of chromoblastomycosis with terbinafine: experience with four cases, J Dermatolog Treat, 16, 47, 10.1080/09546630410024538
Xibao Z, 2005, Treatment of chromoblastomycosis with terbinafine: a report of four cases, J Dermatolog Treat, 16, 121, 10.1080/09546630510033203
McGinnis MR, 1998, In vitro evaluation of terbinafine and itraconazole against dematiaceous fungi, Med Mycol, 36, 243, 10.1080/02681219880000371
Caligiorne RB, 1999, In vitro susceptibility of chromoblastomycosis and phaeohyphomycosis agents to antifungal drugs, Med Mycol, 37, 405, 10.1046/j.1365-280X.1999.00245.x
Kumarasinghe SP, 2000, Itraconazole pulse therapy in chromoblastomycosis, Eur J Dermatol, 10, 220
Ungpakorn R, 2006, Pulse itraconazole 400 mg daily in the treatment of chromoblastomycosis, Clin Exp Dermatol, 31, 245, 10.1111/j.1365-2230.2005.02024.x
Gupta AK, 2002, Alternate week and combination itraconazole and terbinafine therapy for chromoblastomycosis caused by Fonsecaea pedrosoi in Brazil, Med Mycol, 40, 529, 10.1080/mmy.40.5.529.534
Koo S, 2010, Fonsecaea monophora cerebral phaeohyphomycosis: case report of successful surgical excision and voriconazole treatment and review, Med Mycol, 48, 769, 10.3109/13693780903471081
Lima AM, 2016, Response of chromoblastomycosis to voriconazole, An Bras Dermatol, 91, 679, 10.1590/abd1806-4841.20165142
Criado PR, 2011, Extensive long-standing chromomycosis due to Fonsecaea pedrosoi: three cases with relevant improvement under voriconazole therapy, J Dermatolog Treat, 22, 167, 10.3109/09546630903585074
Negroni R, 2005, Posaconazole treatment of refractory eumycetoma and chromoblastomycosis, Rev Inst Med Trop Sao Paulo, 47, 339, 10.1590/S0036-46652005000600006
Lopes CF, 1978, Six years experience in treatment of chromomycosis with 5-fluorocytosine, Int J Dermatol, 17, 414, 10.1111/ijd.1978.17.5.414
Park SG, 2005, A case of chromoblastomycosis with an unusual clinical manifestation caused by Phialophora verrucosa on an unexposed area: treatment with a combination of amphotericin B and 5-flucytosine, Br J Dermatol, 152, 560, 10.1111/j.1365-2133.2005.06424.x
Bolzinger T, 1991, Traitement de quatrecas de chromomycose à Fonsecaea pedrosoi par l'association 5-fluorocytosine-itraconazole, Nouv Dermatol, 10, 462
Antonello VS, 2010, Treatment of severe chromoblastomycosis with itraconazole and 5-flucytosine association, Rev Inst Med Trop Sao Paulo, 52, 329, 10.1590/S0036-46652010000600008
Kubala L, 2003, The effect of (1-3)-ß-d-glucans, carboxymethylglucan and schizophyllan on human leukocytes in vitro, Carbohydr Res, 338, 2835, 10.1016/j.carres.2003.09.007
Meira DA, 1996, The use of glucan as immunostimulant in the treatment of paracoccidioidomycosis, Am J Trop Med Hyg, 55, 496, 10.4269/ajtmh.1996.55.496
Azevedo Cde M, 2008, The use of glucan as immunostimulant in the treatment of a severe case of chromoblastomycosis, Mycoses, 51, 341, 10.1111/j.1439-0507.2007.01485.x
Azevedo CMPS, 2005, PO247 - Efeito da glucana em um caso de cromoblastomicose refratário a antifúngico In: Pôsters apresentados no 60 o Congresso da Sociedade Brasileira de Dermatologia. Departamento de Micologia; 2005 set 10 a 14, An Bras Dermatol, 80, S226
Buates S, 1999, Treatment of experimental leishmaniasis with the immunomodulators imiquimod and S-28463 efficacy and mode of action, J Infect Dis, 179, 1485, 10.1086/314782
Sousa Mda G, 2011, Restoration of pattern recognition receptor costimulation to treat chromoblastomycosis, a chronic fungal infection of the skin, Cell Host Microbe, 9, 436, 10.1016/j.chom.2011.04.005